1-20 of 20
Wenjun Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aberrant Splicing in CHEK1 Is a Driver of Megakaryocytic Dysplasia in U2AF1 S34F Mutant Myelodysplastic Syndromes

Wenjun Zhang, Jinqin Liu, Gang Huang, Zhijian Xiao, Bing Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 3193.
https://doi.org/10.1182/blood-2024-200825
Published: 2024
Journal Articles

EX103, a Newly Re-Designed CD20×CD3 Molecule, Induces High Response in Heavily Pretreated Relapsed/Refractory (R/R) Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL)

Mingyuan Sun, Lugui Qiu, Keshu Zhou, Kai Hu, Chunkang Chang, Dong Wu, Zhenling Li, Ming Gong, Wenjun Zhang, Daniel Yang, Jiali Lu, Junyuan Qi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3103.
https://doi.org/10.1182/blood-2024-193606
Published: 2024
Journal Articles

The Impact of Immune Function on Hematopoietic Reconstitution and Infection in Patients with Lymphoma after Autologous Hematopoietic Stem Cell Transplantation

Renzhi Hu, Jun Liu, Xiping Liang, Wenjun Zhang, Yixing Zhou, Qiying Li, Yao Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6296.
https://doi.org/10.1182/blood-2023-181416
Published: 2023
Journal Articles

Clinical Characteristics of Long-Term Survivors Treated with BCMA CAR T Cell

Fangce WANG, Bing Li, Ping Li, Shiguang Ye, Lili Zhou, Wenjun Zhang, Shaoguang Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6865.
https://doi.org/10.1182/blood-2023-185161
Published: 2023
Journal Articles

Zanubrutinib Combined with R-CHOP As the First-Line Treatment for Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Prospective Phase II Trial in China

Chongling Hu, Tao Yang, Li Jun, Wenjun Zhang, Bingling Guo, Chaoyu Wang, Jun Liu, Chunyan Xiao, Dehong Huang, Zailin Yang, Tingting Liu, Jieping Li, Yingyu Nan, Yao Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6285.
https://doi.org/10.1182/blood-2023-188060
Published: 2023
Journal Articles

ITGB3 Promotes the Progression of JAK2V617F-Positive Myeloproliferative Neoplams By Regulating Calreticulin to Inhibit Cellular Autophagy

Jie Zhou, Wenjun Zhang, Baoqing Yang, Hao Wu, Bing Li, Shaoguang Li, Aibin Liang, Jianfei Fu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2748.
https://doi.org/10.1182/blood-2023-181816
Published: 2023
Journal Articles

Clinical Study on the Efficacy and Safety of Peg Rhg CSF for Autologous Hematopoietic Stem Cell Mobilization in Lymphoma and Multiple Myeloma：a Randomized Controlled, Multicenter Clinical Study

Lingqian Zhang, Li Jun, Wenjun Zhang, Bingling Guo, Chongling Hu, Xi Quan, Chensi Zeng, Yao Ding, Dehong Huang, Chunyan Xiao, Jun Liu, Jing Wu, Chaoyu Wang, Xiping Liang, Zailin Yang, Shunsi Liang, Renzhi Hu, Tingting Liu, Qiying Li, Jieping Li, Yingyu Nan, Ying Xiang, Yao Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2222.
https://doi.org/10.1182/blood-2023-182517
Published: 2023
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Combined with High-Dose Chemotherapy As First-Line Treatment for HIV-Associated Lymphoma: A Retrospective Analysis

Bingling Guo, Renzhi Hu, Xiping Liang, Zailin Yang, Tao Yang, Chaoyu Wang, Chongling Hu, Wenjun Zhang, Chunyan Xiao, Jun Liu, Dehong Huang, Tingting Liu, Yingyu Nan, Jieping Li, Yao Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6295.
https://doi.org/10.1182/blood-2023-181393
Published: 2023
Journal Articles

U2AF1 S34F Mutation Promote Megakaryopoiesis and Fibrogenesis in MDS

Wenjun Zhang, Jinqin Liu, Lin Yang, Yiru Yan, Tiejun Qin, Zefeng Xu, Gang Huang, Bing Li, Zhijian Xiao
Journal: Blood
Blood (2023) 142 (Supplement 1): 5685.
https://doi.org/10.1182/blood-2023-185678
Published: 2023
Journal Articles

EX103, a Novel CD20xCD3 Bispecific Antibody, Showed a Favorable Safety and Potent Single-Agent Antitumor Activity in Heavily Pretreated Relapsed/Refractory Patients with B-Cell Non-Hodgkin Lymphoma

Junyuan Qi, Mingyuan Sun, Keshu Zhou, Chunyan Ji, Fei Lu, Chunkang Chang, Wenjun Zhang, Daniel Yang, Jiali Lu, Jisen Li, Ying Cheng, Yanfei Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6230.
https://doi.org/10.1182/blood-2023-173486
Published: 2023
Journal Articles

Unique Clinical Features and Mutation Profile in De Novo Myelodysplastic Syndromes with MF-1 and a Proposed Model for Distinguishing MDS with MF-2/3 from TN-PMF Based on Clinical and Genetic Covariates

Junying Wu, Wenjun Zhang, Peihong Zhang, Tiejun Qin, Zefeng Xu, Qi Sun, Yujiao Jia, Shiqiang Qu, Bing Li, Huijun Wang, Lijuan Pan, Jinqin Liu, Yudi Zhang, Xin Yan, Robert Peter Gale, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 4058–4059.
https://doi.org/10.1182/blood-2022-163019
Published: 2022
Journal Articles

Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial

Tao Yang, Jun Li, Wenjun Zhang, Bingling Guo, Chongling Hu, Xi Quan, Chensi Zeng, Yao Ding, Dehong Huang, Chunyan Xiao, Jun Liu, Jing Wu, Chaoyu Wang, Xiping Liang, Lingqian Zhang, Zailin Yang, Shunsi Liang, Renzhi Hu, Tingting Liu, Qiying Li, Jieping Li, Yingyu Nan, Ying Xiang, Yao Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 9540–9541.
https://doi.org/10.1182/blood-2022-168308
Published: 2022
Journal Articles

Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab Plus Bendamustine in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Single Center Analysis of Pola Compassionate Use Program (CUP) in China

Tao Yang, Jun Li, Lingqian Zhang, Renzhi Hu, Jing Wu, Yao Ding, Xiping Liang, Xi Quan, Chongling Hu, Wenjun Zhang, Bingling Guo, Chaoyu Wang, Qiying Li, Jieping Li, Yingyu Nan, Ying Xiang, Yao Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12139.
https://doi.org/10.1182/blood-2022-168656
Published: 2022
Journal Articles

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with HIV-Associated Aggressive B-Cell NHL in China

Chaoyu Wang, Jun Liu, Bingling Guo, Renzhi Hu, Tingting Liu, Jing Wu, Yao Ding, Chongling Hu, Shunsi Liang, Chunyan Xiao, Dehong Huang, Tao Yang, Wenjun Zhang, Zailin Yang, Jieping Li, Yingyu Nan, Qiying Li, Ying Xiang, Yao Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 11925.
https://doi.org/10.1182/blood-2022-155674
Published: 2022
Journal Articles

Developing a Novel Anti-CD19/CD20 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Relapsed/Refractory (r/r) B-Cell NHL

Lili Zhou, MD, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Shiguang Ye, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Yanfeng Li, MS, Liping Lan, MS, Shicheng Chen, Lin Guo, PhD, Qingsong Zhang, MS, Jiangqin Zheng, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-137826
Published: 2020
Journal Articles

Early Clinical Results of a Novel Anti-CD20 Chimeric Antigen Receptor (CAR)-T Cell Therapy for B-Cell NHL Patients Who Are Relapsed/Resistant Following CD19 CAR-T Therapy

Shiguang Ye, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Lili Zhou, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Liping Lan, MS, Shicheng Chen, Yutian Wei, MS, Wangqin Shu, MS, Chen Ye, Dan Zhang, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-138538
Published: 2020
Journal Articles

Activation of JAK2/STAT5 Pathway Reduces Expression Level of DNMT3a in MPN Cell Line

Jie Zhou, Aibin Liang, PhD, Shaoguang Li, Wenjun Zhang, Jianfei FU, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5394.
https://doi.org/10.1182/blood-2019-125434
Published: 2019
Journal Articles

STAT3 Is Required for Notch-Induced Leukemogenesis, and Functions As a Critical Survival Effector in T-Cell Leukemia

Jixin Ding, PhD, Ana L. Batista, PhD, Sonia Rodriguez-Rodriguez, PhD, Lin Wang, PhD, Wenjun Zhang, PhD, Akira Moh, PhD, Xin-Yuan Fu, PhD, Weinian Shou, PhD, Nadia Carlesso, MD, PhD, Angelo A Cardoso, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 920.
https://doi.org/10.1182/blood.V118.21.920.920
Published: 2011
Journal Articles

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Paul A. Moore, Wenjun Zhang, G. Jonah Rainey, Steve Burke, Hua Li, Ling Huang, Sergey Gorlatov, Maria Concetta Veri, Sudeepta Aggarwal, Yinhua Yang, Kalpana Shah, Linda Jin, Sunan Zhang, Leilei He, Tengfei Zhang, Valentina Ciccarone, Scott Koenig, Ezio Bonvini, Syd Johnson
Journal: Blood
Blood (2011) 117 (17): 4542–4551.
https://doi.org/10.1182/blood-2010-09-306449
Published: 2011
Includes: Supplemental data
Journal Articles

STAT3 Deletion after Birth Results in Marked Decreases in Absolute Numbers and Cell Cycling Status of Marrow and Spleen Myeloid Progenitor Cells, and STAT3 Is a Critical Molecule in Mediating Synergistically Stimulated Progenitor Cell Proliferation.

Hal E. Broxmeyer, PhD, Scott Cooper, BSc, Giao Hangoc, DVM, Wenjun Zhang, PhD, Akira Moh, PhD, Thomas Welte, PhD, Xin-Yuan Fu, PhD
Journal: Blood
Blood (2005) 106 (11): 1346.
https://doi.org/10.1182/blood.V106.11.1346.1346
Published: 2005